Ignite Creation Date:
2025-12-25 @ 3:49 AM
Ignite Modification Date:
2026-03-01 @ 10:02 AM
Study NCT ID:
NCT06439602
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2025-04-15
First Post:
2024-05-28
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Phase 3 Evaluation of Efficacy and Safety of AR882 in Gout Patients (AR882-302)
Sponsor:
Arthrosi Therapeutics
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2024-06-26
Start Date Type:
ACTUAL
Primary Completion Date:
2026-11
Primary Completion Date Type:
ESTIMATED
Completion Date:
2026-11
Completion Date Type:
ESTIMATED
First Submit Date:
2024-05-28
First Submit QC Date:
None
Study First Post Date:
2024-06-03
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-04-11
Last Update Post Date:
2025-04-15
Last Update Post Date Type:
ACTUAL